nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—artery—uterine cancer	0.136	0.399	CbGeAlD
Tirofiban—ITGB3—epithelium—uterine cancer	0.0452	0.132	CbGeAlD
Tirofiban—ITGB3—decidua—uterine cancer	0.0427	0.125	CbGeAlD
Tirofiban—ITGB3—renal system—uterine cancer	0.0419	0.123	CbGeAlD
Tirofiban—ITGB3—female reproductive system—uterine cancer	0.0336	0.0982	CbGeAlD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.0281	0.0516	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—PARVA—uterine cancer	0.0228	0.042	CbGpPWpGaD
Tirofiban—ITGA2B—lymph node—uterine cancer	0.0225	0.0657	CbGeAlD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1C—uterine cancer	0.0216	0.0398	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.0216	0.0397	CbGpPWpGaD
Tirofiban—ITGB3—lymph node—uterine cancer	0.0196	0.0574	CbGeAlD
Tirofiban—ITGA2B—ECM proteoglycans—DCN—uterine cancer	0.016	0.0294	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—DCN—uterine cancer	0.0123	0.0227	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—MME—uterine cancer	0.012	0.022	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—SOCS3—uterine cancer	0.0109	0.02	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—MET—uterine cancer	0.0107	0.0196	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—ZEB1—uterine cancer	0.0101	0.0186	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—HMGA1—uterine cancer	0.00971	0.0178	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—PLXNA3—uterine cancer	0.00946	0.0174	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—SOCS3—uterine cancer	0.00837	0.0154	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—MET—uterine cancer	0.00823	0.0151	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—CDH1—uterine cancer	0.00806	0.0148	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—PLXNA3—uterine cancer	0.00729	0.0134	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—SOCS3—uterine cancer	0.00727	0.0134	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—PLXNA3—uterine cancer	0.00675	0.0124	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—IGF1R—uterine cancer	0.00667	0.0123	CbGpPWpGaD
Tirofiban—ITGA2B—Ephrin B reverse signaling—PIK3CA—uterine cancer	0.00596	0.0109	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—CTNNB1—uterine cancer	0.00595	0.0109	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—CDH1—uterine cancer	0.00557	0.0102	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—YWHAE—uterine cancer	0.00529	0.00971	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—PLXNA3—uterine cancer	0.0052	0.00956	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—VEGFA—uterine cancer	0.0051	0.00937	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—AKT1—uterine cancer	0.00472	0.00868	CbGpPWpGaD
Tirofiban—ITGB3—Ephrin B reverse signaling—PIK3CA—uterine cancer	0.00459	0.00843	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—DCN—uterine cancer	0.00456	0.00838	CbGpPWpGaD
Tirofiban—Swelling—Progesterone—uterine cancer	0.00432	0.0379	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—CDH1—uterine cancer	0.00429	0.00788	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—PIK3CA—uterine cancer	0.00409	0.00752	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—PIK3CA—uterine cancer	0.00399	0.00733	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—VEGFA—uterine cancer	0.00393	0.00722	CbGpPWpGaD
Tirofiban—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.0344	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CDKN2B—uterine cancer	0.0038	0.00699	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00375	0.00689	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—AKT1—uterine cancer	0.00367	0.00674	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—AKT1—uterine cancer	0.00364	0.00668	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—IGF1R—uterine cancer	0.00358	0.00658	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—HNF1B—uterine cancer	0.00355	0.00652	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—DCN—uterine cancer	0.00351	0.00646	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—CDKN1B—uterine cancer	0.00348	0.00639	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—SMAD3—uterine cancer	0.00347	0.00638	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—PIK3CA—uterine cancer	0.00342	0.00629	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1B—uterine cancer	0.00313	0.00575	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—VEGFA—uterine cancer	0.0031	0.0057	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—uterine cancer	0.00309	0.00568	CbGpPWpGaD
Tirofiban—Pain—Carboplatin—uterine cancer	0.00305	0.0268	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.00296	0.00543	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CTNNB1—uterine cancer	0.00295	0.00543	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—VEGFA—uterine cancer	0.00289	0.00532	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00289	0.00531	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MET—uterine cancer	0.00284	0.00523	CbGpPWpGaD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—AKT1—uterine cancer	0.00283	0.00519	CbGpPWpGaD
Tirofiban—Body temperature increased—Carboplatin—uterine cancer	0.00282	0.0248	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—AKT1—uterine cancer	0.00279	0.00514	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MET—uterine cancer	0.00276	0.00507	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—IGF1R—uterine cancer	0.00276	0.00507	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HNF1B—uterine cancer	0.00273	0.00502	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—uterine cancer	0.00272	0.005	CbGpPWpGaD
Tirofiban—Haemoglobin—Progesterone—uterine cancer	0.00265	0.0233	CcSEcCtD
Tirofiban—Haemorrhage—Progesterone—uterine cancer	0.00264	0.0232	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—PIK3CA—uterine cancer	0.00264	0.00484	CbGpPWpGaD
Tirofiban—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.0229	CcSEcCtD
Tirofiban—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.0224	CcSEcCtD
Tirofiban—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.0214	CcSEcCtD
Tirofiban—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0211	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—IRF1—uterine cancer	0.0024	0.00441	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—VEGFA—uterine cancer	0.00239	0.00439	CbGpPWpGaD
Tirofiban—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.021	CcSEcCtD
Tirofiban—ITGB3—IL4-mediated signaling events—PIK3CA—uterine cancer	0.00229	0.00421	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.00228	0.00418	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—PIK3CA—uterine cancer	0.00226	0.00415	CbGpPWpGaD
Tirofiban—Swelling—Etoposide—uterine cancer	0.00221	0.0194	CcSEcCtD
Tirofiban—Haematemesis—Epirubicin—uterine cancer	0.00217	0.019	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—AKT1—uterine cancer	0.00215	0.00396	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—CTNNB1—uterine cancer	0.00215	0.00395	CbGpPWpGaD
Tirofiban—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.0188	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—uterine cancer	0.00213	0.00391	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—MET—uterine cancer	0.00213	0.00391	CbGpPWpGaD
Tirofiban—Haemoptysis—Epirubicin—uterine cancer	0.00203	0.0179	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—CTNNB1—uterine cancer	0.00203	0.00373	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ERBB2—uterine cancer	0.00202	0.00371	CbGpPWpGaD
Tirofiban—Haematemesis—Doxorubicin—uterine cancer	0.00201	0.0176	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—NRAS—uterine cancer	0.00199	0.00366	CbGpPWpGaD
Tirofiban—Hypertension—Progesterone—uterine cancer	0.00198	0.0174	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—VEGFA—uterine cancer	0.00189	0.00348	CbGpPWpGaD
Tirofiban—Haemoptysis—Doxorubicin—uterine cancer	0.00188	0.0165	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—HRAS—uterine cancer	0.00188	0.00345	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Progesterone—uterine cancer	0.00187	0.0165	CcSEcCtD
Tirofiban—Oedema—Progesterone—uterine cancer	0.00187	0.0165	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NRAS—uterine cancer	0.00187	0.00344	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—AKT1—uterine cancer	0.00187	0.00344	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PTEN—uterine cancer	0.00185	0.0034	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IRF1—uterine cancer	0.00185	0.0034	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—AKT1—uterine cancer	0.00185	0.00339	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—CDH1—uterine cancer	0.00184	0.00338	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Progesterone—uterine cancer	0.00181	0.0159	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MET—uterine cancer	0.0018	0.00331	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—VEGFA—uterine cancer	0.00179	0.00329	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—NRAS—uterine cancer	0.00177	0.00325	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CTNNB1—uterine cancer	0.00176	0.00324	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—uterine cancer	0.00174	0.00319	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—PTEN—uterine cancer	0.00172	0.00316	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.00171	0.00315	CbGpPWpGaD
Tirofiban—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.0149	CcSEcCtD
Tirofiban—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.0149	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—EP300—uterine cancer	0.00169	0.00311	CbGpPWpGaD
Tirofiban—Chills—Dactinomycin—uterine cancer	0.00167	0.0147	CcSEcCtD
Tirofiban—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0146	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—uterine cancer	0.00166	0.00305	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—AKT1—uterine cancer	0.00166	0.00304	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NRAS—uterine cancer	0.00165	0.00304	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.0144	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—uterine cancer	0.00161	0.00296	CbGpPWpGaD
Tirofiban—Pain—Progesterone—uterine cancer	0.0016	0.0141	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.00157	0.00289	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SMAD3—uterine cancer	0.00157	0.00288	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKR1B10—uterine cancer	0.00156	0.00286	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—uterine cancer	0.00155	0.00285	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—uterine cancer	0.00155	0.00285	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—uterine cancer	0.00152	0.00279	CbGpPWpGaD
Tirofiban—Urticaria—Progesterone—uterine cancer	0.00149	0.0131	CcSEcCtD
Tirofiban—Body temperature increased—Progesterone—uterine cancer	0.00148	0.013	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—PIK3CA—uterine cancer	0.00148	0.00272	CbGpPWpGaD
Tirofiban—Myocardial infarction—Etoposide—uterine cancer	0.00147	0.0129	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.00146	0.00268	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—uterine cancer	0.00145	0.00266	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—uterine cancer	0.00142	0.00261	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—CDH1—uterine cancer	0.00142	0.0026	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—PIK3CA—uterine cancer	0.0014	0.00257	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MET—uterine cancer	0.00139	0.00255	CbGpPWpGaD
Tirofiban—Hypersensitivity—Progesterone—uterine cancer	0.00138	0.0121	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.00138	0.00253	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—uterine cancer	0.00137	0.00252	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—CTNNB1—uterine cancer	0.00136	0.0025	CbGpPWpGaD
Tirofiban—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.0118	CcSEcCtD
Tirofiban—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.0118	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—PTEN—uterine cancer	0.00132	0.00243	CbGpPWpGaD
Tirofiban—Oedema—Dactinomycin—uterine cancer	0.00132	0.0116	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ERBB2—uterine cancer	0.00132	0.00242	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PIK3CA—uterine cancer	0.00131	0.0024	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Dactinomycin—uterine cancer	0.0013	0.0114	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—uterine cancer	0.00129	0.00237	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RNF43—uterine cancer	0.00129	0.00237	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MET—uterine cancer	0.00128	0.00236	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—AKT1—uterine cancer	0.00128	0.00234	CbGpPWpGaD
Tirofiban—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.011	CcSEcCtD
Tirofiban—Dizziness—Progesterone—uterine cancer	0.00124	0.0109	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—PIK3CA—uterine cancer	0.00121	0.00223	CbGpPWpGaD
Tirofiban—Chills—Etoposide—uterine cancer	0.00121	0.0106	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—uterine cancer	0.00121	0.00222	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—uterine cancer	0.00121	0.00222	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—AKT1—uterine cancer	0.00121	0.00222	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SMAD3—uterine cancer	0.00121	0.00222	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKR1B10—uterine cancer	0.0012	0.0022	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—uterine cancer	0.0012	0.0022	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—INHBA—uterine cancer	0.00118	0.00217	CbGpPWpGaD
Tirofiban—Headache—Progesterone—uterine cancer	0.00117	0.0103	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—AKT1—uterine cancer	0.00114	0.0021	CbGpPWpGaD
Tirofiban—Pain—Dactinomycin—uterine cancer	0.00113	0.00994	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—uterine cancer	0.00112	0.00206	CbGpPWpGaD
Tirofiban—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00986	CcSEcCtD
Tirofiban—Nausea—Progesterone—uterine cancer	0.00111	0.00977	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.00108	0.00198	CbGpPWpGaD
Tirofiban—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00934	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—AKR1C1—uterine cancer	0.00106	0.00195	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.00106	0.00195	CbGpPWpGaD
Tirofiban—Body temperature increased—Dactinomycin—uterine cancer	0.00105	0.00919	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—AKT1—uterine cancer	0.00102	0.00188	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—uterine cancer	0.00101	0.00186	CbGpPWpGaD
Tirofiban—Hypertension—Etoposide—uterine cancer	0.00101	0.0089	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—VEGFA—uterine cancer	0.00101	0.00186	CbGpPWpGaD
Tirofiban—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00885	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—NRAS—uterine cancer	0.001	0.00184	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RNF43—uterine cancer	0.000994	0.00183	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—AKT1—uterine cancer	0.000991	0.00182	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MET—uterine cancer	0.00099	0.00182	CbGpPWpGaD
Tirofiban—Hypersensitivity—Dactinomycin—uterine cancer	0.000975	0.00857	CcSEcCtD
Tirofiban—Anaphylactic shock—Etoposide—uterine cancer	0.000958	0.00842	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—uterine cancer	0.000939	0.00173	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Etoposide—uterine cancer	0.000938	0.00824	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—PIK3CA—uterine cancer	0.000935	0.00172	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Etoposide—uterine cancer	0.000926	0.00814	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—INHBA—uterine cancer	0.000909	0.00167	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—AKT1—uterine cancer	0.000878	0.00161	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—HRAS—uterine cancer	0.000865	0.00159	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—uterine cancer	0.000862	0.00158	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.000828	0.00152	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CTNNB1—uterine cancer	0.000822	0.00151	CbGpPWpGaD
Tirofiban—Pain—Etoposide—uterine cancer	0.000819	0.0072	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—AKR1C1—uterine cancer	0.000818	0.0015	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKR1C3—uterine cancer	0.000818	0.0015	CbGpPWpGaD
Tirofiban—Sweating—Epirubicin—uterine cancer	0.000807	0.00709	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—uterine cancer	0.000803	0.00705	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PGR—uterine cancer	0.000797	0.00146	CbGpPWpGaD
Tirofiban—Nausea—Dactinomycin—uterine cancer	0.000786	0.00691	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—VEGFA—uterine cancer	0.000781	0.00143	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—NRAS—uterine cancer	0.000771	0.00142	CbGpPWpGaD
Tirofiban—Bradycardia—Epirubicin—uterine cancer	0.00077	0.00676	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—EP300—uterine cancer	0.000764	0.0014	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—uterine cancer	0.000764	0.0014	CbGpPWpGaD
Tirofiban—Urticaria—Etoposide—uterine cancer	0.000761	0.00669	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—YWHAE—uterine cancer	0.00076	0.0014	CbGpPWpGaD
Tirofiban—Haemoglobin—Epirubicin—uterine cancer	0.00076	0.00667	CcSEcCtD
Tirofiban—Body temperature increased—Etoposide—uterine cancer	0.000757	0.00665	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—uterine cancer	0.000756	0.00664	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—EP300—uterine cancer	0.000749	0.00138	CbGpPWpGaD
Tirofiban—Sweating—Doxorubicin—uterine cancer	0.000747	0.00656	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—uterine cancer	0.000743	0.00652	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—HRAS—uterine cancer	0.000732	0.00135	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FBXW7—uterine cancer	0.000729	0.00134	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—uterine cancer	0.000723	0.00133	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—uterine cancer	0.000723	0.00133	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NRAS—uterine cancer	0.000714	0.00131	CbGpPWpGaD
Tirofiban—Bradycardia—Doxorubicin—uterine cancer	0.000712	0.00625	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—VEGFA—uterine cancer	0.00071	0.0013	CbGpPWpGaD
Tirofiban—Hypersensitivity—Etoposide—uterine cancer	0.000706	0.0062	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—uterine cancer	0.000703	0.00617	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—NRAS—uterine cancer	0.000701	0.00129	CbGpPWpGaD
Tirofiban—Haemorrhage—Doxorubicin—uterine cancer	0.0007	0.00614	CcSEcCtD
Tirofiban—Chills—Epirubicin—uterine cancer	0.000678	0.00596	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—uterine cancer	0.000677	0.00124	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—uterine cancer	0.000664	0.00122	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STK11—uterine cancer	0.000637	0.00117	CbGpPWpGaD
Tirofiban—Dizziness—Etoposide—uterine cancer	0.000634	0.00556	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—CTNNB1—uterine cancer	0.000633	0.00116	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKR1C3—uterine cancer	0.00063	0.00116	CbGpPWpGaD
Tirofiban—Chills—Doxorubicin—uterine cancer	0.000628	0.00551	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—KRAS—uterine cancer	0.000615	0.00113	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PGR—uterine cancer	0.000614	0.00113	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—uterine cancer	0.000603	0.00111	CbGpPWpGaD
Tirofiban—Headache—Etoposide—uterine cancer	0.0006	0.00527	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—SOCS3—uterine cancer	0.000597	0.0011	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EP300—uterine cancer	0.000588	0.00108	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—YWHAE—uterine cancer	0.000586	0.00108	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—EP300—uterine cancer	0.000577	0.00106	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN2B—uterine cancer	0.000571	0.00105	CbGpPWpGaD
Tirofiban—Nausea—Etoposide—uterine cancer	0.000569	0.005	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—uterine cancer	0.000568	0.00499	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—HRAS—uterine cancer	0.000564	0.00104	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FBXW7—uterine cancer	0.000561	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—uterine cancer	0.000557	0.00102	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1R—uterine cancer	0.000555	0.00102	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—uterine cancer	0.000554	0.00102	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NRAS—uterine cancer	0.00055	0.00101	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—uterine cancer	0.000547	0.001	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NRAS—uterine cancer	0.00054	0.000992	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Epirubicin—uterine cancer	0.000537	0.00472	CcSEcCtD
Tirofiban—Oedema—Epirubicin—uterine cancer	0.000537	0.00472	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—TP53—uterine cancer	0.000536	0.000985	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Epirubicin—uterine cancer	0.000526	0.00462	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—uterine cancer	0.000526	0.00462	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—HRAS—uterine cancer	0.000523	0.00096	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SMAD3—uterine cancer	0.000521	0.000958	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Epirubicin—uterine cancer	0.000519	0.00456	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—HRAS—uterine cancer	0.000513	0.000942	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR2—uterine cancer	0.000497	0.000914	CbGpPWpGaD
Tirofiban—Oedema—Doxorubicin—uterine cancer	0.000497	0.00436	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—uterine cancer	0.000497	0.00436	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—STK11—uterine cancer	0.000491	0.000902	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Doxorubicin—uterine cancer	0.000487	0.00427	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—uterine cancer	0.00048	0.00422	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—KRAS—uterine cancer	0.000474	0.00087	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—uterine cancer	0.000465	0.000854	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—uterine cancer	0.000461	0.000848	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SOCS3—uterine cancer	0.00046	0.000844	CbGpPWpGaD
Tirofiban—Pain—Epirubicin—uterine cancer	0.000459	0.00403	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—AKT1—uterine cancer	0.000453	0.000832	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN2B—uterine cancer	0.00044	0.000808	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1R—uterine cancer	0.000427	0.000785	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—uterine cancer	0.000427	0.000784	CbGpPWpGaD
Tirofiban—Urticaria—Epirubicin—uterine cancer	0.000427	0.00375	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—uterine cancer	0.000425	0.000782	CbGpPWpGaD
Tirofiban—Pain—Doxorubicin—uterine cancer	0.000425	0.00373	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—uterine cancer	0.000425	0.00373	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—TP53—uterine cancer	0.000413	0.000759	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—uterine cancer	0.000403	0.00074	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMAD3—uterine cancer	0.000402	0.000738	CbGpPWpGaD
Tirofiban—Hypersensitivity—Epirubicin—uterine cancer	0.000396	0.00348	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—HRAS—uterine cancer	0.000395	0.000726	CbGpPWpGaD
Tirofiban—Urticaria—Doxorubicin—uterine cancer	0.000395	0.00347	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—uterine cancer	0.000393	0.00345	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—FGFR2—uterine cancer	0.000383	0.000704	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL2—uterine cancer	0.000375	0.000688	CbGpPWpGaD
Tirofiban—Hypersensitivity—Doxorubicin—uterine cancer	0.000366	0.00322	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—AKT1—uterine cancer	0.000356	0.000653	CbGpPWpGaD
Tirofiban—Dizziness—Epirubicin—uterine cancer	0.000355	0.00312	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—AKT1—uterine cancer	0.000349	0.000641	CbGpPWpGaD
Tirofiban—Headache—Epirubicin—uterine cancer	0.000336	0.00296	CcSEcCtD
Tirofiban—Dizziness—Doxorubicin—uterine cancer	0.000329	0.00289	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—ESR1—uterine cancer	0.000328	0.000602	CbGpPWpGaD
Tirofiban—Nausea—Epirubicin—uterine cancer	0.000319	0.0028	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—uterine cancer	0.000312	0.000574	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—uterine cancer	0.000311	0.00273	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—uterine cancer	0.000296	0.000544	CbGpPWpGaD
Tirofiban—Nausea—Doxorubicin—uterine cancer	0.000295	0.00259	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—uterine cancer	0.000289	0.000531	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL2—uterine cancer	0.000289	0.00053	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CTNNB1—uterine cancer	0.000273	0.000502	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—uterine cancer	0.000266	0.000489	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EP300—uterine cancer	0.000254	0.000467	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—uterine cancer	0.000241	0.000442	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—uterine cancer	0.000241	0.000442	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—uterine cancer	0.000238	0.000437	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—uterine cancer	0.000228	0.000419	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—uterine cancer	0.000223	0.000409	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNB1—uterine cancer	0.00021	0.000387	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—uterine cancer	0.000205	0.000377	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—uterine cancer	0.000204	0.000376	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EP300—uterine cancer	0.000196	0.00036	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—uterine cancer	0.000188	0.000345	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—uterine cancer	0.000185	0.000341	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—uterine cancer	0.000183	0.000336	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—uterine cancer	0.000182	0.000334	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—uterine cancer	0.000174	0.000319	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—uterine cancer	0.000158	0.000289	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—uterine cancer	0.000153	0.000282	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—uterine cancer	0.000145	0.000266	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—uterine cancer	0.00014	0.000257	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—uterine cancer	0.000134	0.000246	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—uterine cancer	0.000118	0.000217	CbGpPWpGaD
